Incyte INCY
NASDAQ INCY
$126.75 -1.25 (-0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Incyte (INCY) Capital Expenditures (2010 - 2026)

Incyte's (INCY) quarterly Capital Expenditures came in at $12.4 million in Q2 2026, down 34.92% YoY from $19.1 million in Q2 2025, and up 21.7% on a QoQ basis from $10.2 million in Q1 2026.

Analysis

Incyte (INCY) Capital Expenditures (2010 - 2026) Analysis & Trends

Incyte (INCY) has 17 years of Capital Expenditures data on file, last reported at $12.4 million in Q2 2026.

  • Quarterly Capital Expenditures fell 34.92% year-over-year to $12.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $59.2 million (up 32.18% YoY) and the FY2025 annual result came in at $58.9 million, down 31.76% from the prior year.
  • Capital Expenditures improved to $12.4 million in Q2 2026, from $10.2 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $54.1 million in Q2 2024 to a low of $2.3 million in Q4 2023.
  • A 5-year average of $15.4 million and a median of $12.2 million in 2023 frame the typical range for Capital Expenditures.
  • Annual changes were most pronounced in 2023 — Capital Expenditures tumbled 89.34% — and 2024, when it surged 666.83%.
  • Tracing INCY's Capital Expenditures over 5 years: stood at $21.3 million in 2022, then plunged by 89.34% to $2.3 million in 2023, then surged by 666.83% to $17.4 million in 2024, then advanced by 25.85% to $21.9 million in 2025, then sank by 43.26% to $12.4 million in 2026.
  • The last three Capital Expenditures figures came in at $12.4 million (Q2 2026), $10.2 million (Q1 2026), and $21.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 37.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.29 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 25.02 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 34.68 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 251.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.26 Mn
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn 12.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.41 Mn
Mar 31, 2026 10.20 Mn
Dec 31, 2025 21.88 Mn
Sep 30, 2025 14.75 Mn
Jun 30, 2025 19.07 Mn
Mar 31, 2025 3.17 Mn
Dec 31, 2024 17.38 Mn
Sep 30, 2024 5.19 Mn
Jun 30, 2024 54.14 Mn
Mar 31, 2024 9.55 Mn
Dec 31, 2023 2.27 Mn
Sep 30, 2023 10.98 Mn
Jun 30, 2023 7.34 Mn
Mar 31, 2023 11.91 Mn
Dec 31, 2022 21.27 Mn
Sep 30, 2022 27.81 Mn
Jun 30, 2022 11.74 Mn
Mar 31, 2022 17.01 Mn
Dec 31, 2021 34.46 Mn
Sep 30, 2021 32.15 Mn